Detalhe da pesquisa
1.
The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer.
Int J Clin Oncol
; 20(1): 59-69, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24902933
2.
Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data.
JCO Oncol Pract
; 20(1): 145-153, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37556776